Image – Interventional flashlight

DOI: 10.4244/EIJ-D-18-01171

Percutaneous management of an embolised MANTA large bore arteriotomy closure device

Yam-Hong Wong1, MBBS, MRCP(UK), FHKCP, FHKAM; Ole De Backer1, MD, PhD; Lars Søndergaard1, MD, DMSc; Gintautas Bieliauskas1, MD

Figure 1. Percutaneous management of an embolised MANTA. A) & B) Working mechanism of the MANTA closure device. C) The embolised device and the active contrast extravasation from the arteriotomy wound. D) The further embolised device and successful haemostasis. E) The stabilised device with minimal residual stenosis.

A 74-year-old female with severe aortic valve stenosis was offered transfemoral transcatheter aortic valve implantation (TAVI) due to comorbidities and surgical risks. After an uneventful TAVI, closure of the right femoral arteriotomy was attempted with an 18 Fr MANTA™ vascular closure device (Essential Medical Inc., Exton, PA, USA). This novel closure device consists of a resorbable intravascular toggle and an extravascular haemostatic collagen pad. During application, the collagen pad is gently pushed towards the vessel wall with a pusher and kept in place by a stainless steel suture lock – the only radiopaque component (Figure 1A, Figure 1B).

Initially, vascular closure seemed successful; however, major bleeding occurred approximately 10 seconds after releasing the MANTA device, indicating closure failure. Angiography showed embolisation of the MANTA device distal to the femoral bifurcation, with active contrast extravasation from the arteriotomy wound (Figure 1C). Because of major bleeding, obtaining immediate haemostasis was considered a priority. A 0.018’’ Platinum Plus™ guidewire (Boston Scientific, Marlborough, MA, USA) was introduced via the contralateral side into the superficial femoral artery (SFA). A self-expanding VIABAHN® stent graft (W.L. Gore & Associates, Flagstaff, AZ, USA) was deployed across the arteriotomy. Haemostasis was obtained and confirmed by angiography. Following these interventions, the MANTA device embolised further distally into the SFA (Figure 1D). Different options (percutaneous intervention vs. vascular surgery) were discussed. Considering the patient’s high surgical risk profile, the consensus was to attempt endovascular repair. A second VIABAHN stent was deployed across the MANTA device, catching and pressing it between the endothelium of the SFA and the covered stent. After optimising stent expansion by post-dilatation, angiography confirmed restoration of flow with minimal residual stenosis (Figure 1E). The patient remained asymptomatic and free from limb ischaemia.

Clearly, compared with surgical repair plus embolectomy, the two covered stent grafts came with an additional cost of approximately 4,000 euros. However, this percutaneous, transcatheter bail-out approach resulted in prevention of a major vascular complication, a vascular surgery under general anaesthesia and a prolonged hospitalisation. The patient was already mobile six hours after the procedure and was discharged uneventfully two days after TAVI. At three-month control, duplex ultrasound showed two patent covered stents and a functionally insignificant residual stenosis.

Retrospectively, excessive manual compression (for “track oozing”) after cutting the MANTA connecting suture could have been the root cause of this complication. Retaining the suture until achieving complete haemostasis would have prevented the MANTA device from embolising. Moreover, if distal embolisation of the MANTA device does occur, endovascular bail-out management of this complication is safe and efficient.

Guest Editor

This paper was guest edited by Alec Vahanian, MD, PhD; Department of Cardiology, Hôpital Bichat-Claude Bernard, and University Paris VII, Paris, France.

Conflict of interest statement

The authors have no conflicts of interest to declare. The Guest Editor is a consultant for Edwards Lifesciences.

Volume 15 Number 1
May 20, 2019
Volume 15 Number 1
View full issue


Key metrics

Suggested by Cory
Trending articles
318.3

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
116.5

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
108.3

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
91.6

Image – Interventional flashlight

10.4244/EIJ-D-22-00344 Aug 5, 2022
First dedicated transcatheter leaflet splitting device: the ShortCut device
Tchétché D et al
free
72.15

State-of-the-art

10.4244/EIJ-D-22-00627 Feb 6, 2023
Left atrial appendage occlusion
Holmes D et al
free
68.9

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
49.55

CLINICAL RESEARCH

10.4244/EIJ-D-17-00962 Apr 6, 2018
A new optical coherence tomography-based calcium scoring system to predict stent underexpansion
Fujino A et al
free
42.95

State-of-the-Art Review

10.4244/EIJ-D-21-00145 Sep 20, 2021
Robotics, imaging, and artificial intelligence in the catheterisation laboratory
Beyar R et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved